Compugen reported $2.95M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
aTyr Pharma USD 1.84M 8K Sep/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
RedHill Biopharma USD 214K 142K Jun/2025